2-hydroxyglutarate, an oncometabolite associated with gliomas with IDH mutations, was successfully detected by NMR spectroscopy and assigned for its 1H and 13C spectra by 1H-13C HSQC. Here, IDH1 is linked to central nervous system cancer.